v3.25.4
CONSOLIDATED STATEMENTS OF CASH FLOWS - USD ($)
 12 Months Ended
Nov. 30, 2025
Nov. 30, 2024
Cash Flows from Operating Activities:    
Net income $ 1,329,557 $ 1,915,703
Adjustment to reconcile net income to net cash used in operating activities:    
Interest earned on investments held in Trust Account (2,258,631) (2,484,264)
Change in fair value of derivative liability (92)
Changes in operating assets and liabilities:    
Prepaid expenses 37,960 (49,229)
Accrued offering costs and expenses 240,885 64,125
Net Cash Used in Operating Activities (650,321) (553,665)
Cash Flows from Investing Activities:    
Purchase of investment held in Trust Account (69,345,000)
Cash deposited in Trust Account (750,000)
Cash withdrawn from Trust to pay redeemed public shareholders 51,010,745
Net Cash Provided by (Used in) Investing Activities 50,260,745 (69,345,000)
Cash Flows from Financing Activities:    
Proceeds from issuance of promissory note to related party 600,000
Proceeds from due to target company 575,000
Proceeds from sale of public units 69,000,000
Proceeds from sale of private placement units 2,355,000
Proceeds from issuance of ordinary shares to underwriter 690,000
Proceeds from due from related party 30,900
Payment of underwriter compensation (690,000)
Repayment of promissory note - related party (250,000)
Payment of offering costs (1,097,493)
Payment to redeemed public shareholders (51,010,745)
Net Cash (Used in) Provided by Financing Activities (49,835,745) 70,038,407
Net Change in Cash (225,321) 139,742
Cash, Beginning of Year 264,842 125,100
Cash, End of Year 39,521 264,842
Supplemental Disclosure of Non-cash Financing Activities:    
Issuance of convertible note - recognition of derivative liability 4,630
Reclassification of Derivative Liability to APIC 4,538
Conversion of Class B to Class A shares 172
Initial classification of common stock subject to possible redemption 69,345,000
Accretion of additional paid in capital to accumulated deficit 1,749,946
Remeasurement of common stock subject to possible redemption 3,008,631 2,484,264
Deferred underwriting fee payable $ 2,415,000